For example, in characterizing a PRL-driven mammary cancer mouse line (NRL-PRL), genomic analyses uncovered consistent oncogenic KRAS somatic mutations/amplifications in all primary tumors, which was not found in pre-neoplastic glands26. Here, PRL is linked to breast cancer.